News
Studies suggest new key to ‘switching off’ hypertension
A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood...
Press Releases
Investment Group Acquires Metrics Champion Consortium to Drive Adoption and Growth
The Metrics Champion Consortium (MCC) board of directors announced today that the organization has been sold to a group of investors. ...
News
New plan of attack in cancer fight
New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for...
Press Releases
Oncodesign awarded accreditation of its research center by international association, AAALAC
Oncodesign, a contract research laboratory for the discovery of new anticancer therapies, today announces that its Dijon-based research center has received AAALAC certification. ...
News
Uncovering a healthier remedy for chronic pain
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative. ...
Press Releases
Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain...
News
Benefits of Pradaxa® maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure
Published in the European Journal of Heart Failure1, results from a new sub-analysis of the RE-LY®* trial demonstrate important benefits of Pradaxa® (dabigatran etexilate)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read